{"id":"W4387836897","doi":"10.1016/j.annonc.2023.09.563","title":"386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"AstraZeneca","keywords":"Medicine; Trastuzumab; Oncology; Metastatic breast cancer; Breast cancer; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104152,0.0002294088,0.0009559506,0.0002732203,0.00005617006,0.000006034567,0.0003412766,0.0001384677,0.0001026431],"category_scores_gemma":[0.0003826944,0.0001657043,0.00023851,0.001575867,0.000428291,0.00007459096,0.00009022372,0.000467965,0.00001229746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002528954,"about_ca_system_score_gemma":0.001480432,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007978094,"about_ca_topic_score_gemma":0.001486234,"domain_scores_codex":[0.9969559,0.0006605817,0.0007893363,0.0004029241,0.0006188749,0.0005723776],"domain_scores_gemma":[0.9972645,0.001258374,0.0003957017,0.0004558744,0.0004987784,0.0001267857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5884726,0.005128777,0.0006567332,0.0001500398,0.001029109,0.0002158682,0.00313766,0.0002297907,0.01883764,0.0000311182,0.02670302,0.3554076],"study_design_scores_gemma":[0.6870335,0.05852271,0.1123075,0.0008134126,0.0003212281,0.00003788327,0.0007526918,0.001025852,0.1099832,0.0001098536,0.02870871,0.0003834427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785149,0.0003554224,0.000001131643,0.01562846,0.0004398863,0.001816521,0.0007891468,0.00003483313,0.002419684],"genre_scores_gemma":[0.9963064,0.001923351,0.00001520784,0.0005583109,0.0003755694,0.000262073,0.00008217659,0.00003484563,0.000442043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3550242,"threshold_uncertainty_score":0.9986278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.215818782700106,"score_gpt":0.5112288047317133,"score_spread":0.2954100220316073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}